Feb 01, 2024 / 01:00PM GMT
Presentation
Feb 01, 2024 / 01:00PM GMT
=====================
Corporate Participants
=====================
* Alan Hippe
Roche Holding AG - Chief Financial & Information Officer
* Bruno Eschli
Roche Holding AG - Head of IR
* Matthew Sause
Roche Diagnostics Corporation - CEO
* Teresa A. Graham
Roche Holding AG - CEO of Roche Pharmaceuticals
* Thomas Schinecker
Roche Holding AG - CEO
=====================
Conference Call Participants
=====================
* Charles David Mabbutt
Morgan Stanley, Research Division - Research Associate
* Emmanuel Douglas Papadakis
Deutsche Bank AG, Research Division - European Head of Biopharma
* John Priestner
JPMorgan Chase & Co, Research Division - Research Analyst
* Matthew Weston
UBS Investment Bank, Research Division - Analyst
* Richard J. Parkes
BNP Paribas Exane, Research Division - Head of Pharmaceutical and Biotechnology & Analyst
* Richard Wagner
* Sachin Jain
Roche Holding AG
(XSWX:ROP)
CHF
332
+6.8 (+2.09%)
Market Cap: 264.93 Bil
Enterprise Value: 286.73 Bil
PE Ratio: 20.28
PB Ratio: 7.66
GF Score: 79/100 Full Year 2023 Roche Holding AG Earnings Presentation Transcript
Feb 01, 2024 / 01:00PM GMT
Release Date Price:
CHF233.5
(-5.50%)
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |

30-Day 100% money back guarantee
Subscription fee may be tax deductible.
Excellent 

4.6 out of 5
Trustpilot